MEDICAL SERVICES

EDUCATION

Medical School

  • Yale University School of Medicine , New Haven , CT

Internship

Internal Medicine - Pediatrics
  • Combined Internship at Brigham and Women's Hospital and Boston Children's Hospital , Boston , MA

Residency

Internal Medicine - Pediatrics
  • Boston Combined Residency Program (BCRP) , Boston , MA

Fellowship

Pediatric Hematology - Oncology
  • Boston Children's Hospital/ Dana-Farber Cancer Institute , Boston , MA

PROFESSIONAL HISTORY

Dr. Archer’s work has focused on exploration of the epidemiology of blood and cancer disorders in Haiti and efforts to develop safe and cost-effective strategies to address them. In Haiti, she has established a newborn screening and management program for sickle cell disease.  She is in the process of testing the effectiveness of an illustrative education curriculum for Haitian parents of newborns recently diagnosed with sickle cell disease. While developing the sickle cell disease program in Haiti, she has also worked on a number of domestic clinical research projects that assess the role of clinical testing.  She hopes that investigations focused on clinical testing will also inform her practice in resource limited settings.

CERTIFICATIONS

  • American Board of Internal Medicine

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Archer NM, Forbes PW, Dargie J, Manganella J, Licameli GR, Kenna MA, Brugnara C. Association of Blood Type With Postsurgical Mucosal Bleeding in Pediatric Patients Undergoing Tonsillectomy With or Without Adenoidectomy. JAMA Netw Open. 2020 Mar 02; 3(3):e201804. View abstract
  2. Archer NM, Petersen N, Duraisingh MT. Fetal hemoglobin does not inhibit Plasmodium falciparum growth. Blood Adv. 2019 07 23; 3(14):2149-2152. View abstract
  3. Rivera A, Vandorpe DH, Shmukler BE, Andolfo I, Iolascon A, Archer NM, Shabani E, Auerbach M, Hamerschlak N, Morton J, Wohlgemuth JG, Brugnara C, Snyder LM, Alper SL. Erythrocyte ion content and dehydration modulate maximal Gardos channel activity in KCNN4 V282M/+ hereditary xerocytosis red cells. Am J Physiol Cell Physiol. 2019 08 01; 317(2):C287-C302. View abstract
  4. Saint Fleur R, Archer N, Hustace T, Louis RJ, Bellevue R, Gautier J, Lerebours E, Voltaire M, Alvarez O. Capacity building and networking to make newborn screening for sickle cell disease a reality in Haiti. Blood Adv. 2018 11 30; 2(Suppl 1):54-55. View abstract
  5. Archer NM, Petersen N, Clark MA, Buckee CO, Childs LM, Duraisingh MT. Resistance to Plasmodium falciparum in sickle cell trait erythrocytes is driven by oxygen-dependent growth inhibition. Proc Natl Acad Sci U S A. 2018 07 10; 115(28):7350-7355. View abstract
  6. Archer NM, Forbes PW, Brugnara C. Knowledge of Blood Group Decreases von Willebrand Factor Panel Testing in Children. Hemasphere. 2017 Dec; 1(1):e3. View abstract
  7. Irace AL, Adil EA, Archer NM, Silvera VM, Perez-Atayde A, Rahbar R. Pediatric sialoblastoma: Evaluation and management. Int J Pediatr Otorhinolaryngol. 2016 Aug; 87:44-9. View abstract
  8. Archer N, Galacteros F, Brugnara C. 2015 Clinical trials update in sickle cell anemia. Am J Hematol. 2015 Oct; 90(10):934-50. View abstract
  9. Archer NM, Brugnara C. Diagnosis of iron-deficient states. Crit Rev Clin Lab Sci. 2015; 52(5):256-72. View abstract
  10. Archer NM, Brugnara C. Diagnosis of iron-deficient states. Crit Rev Clin Lab Sci. 2015 Aug 14; 1-17. View abstract
  11. Archer NM, Amorim RP, Naves R, Hettmer S, Diller LR, Ribeiro KB, Rodriguez-Galindo C. An Increased Risk of Second Malignant Neoplasms After Rhabdomyosarcoma: Population-Based Evidence for a Cancer Predisposition Syndrome? Pediatr Blood Cancer. 2016 Feb; 63(2):196-201. View abstract
  12. Archer NM, Samnaliev M, Grace R, Brugnara C. The utility of the DDAVP challenge test in children with low von Willebrand factor. Br J Haematol. 2015 Sep; 170(6):884-6. View abstract
  13. Archer N, Collins NB, Croteau S, Hong AL, Kamihara J, Kim D, Kort K, Mersereau R, Mosadegh S, Billett A. Use of a fever fast track tool to reduce time to antibiotic dose in febrile pediatric oncology patients. J Clin Oncol. 2014 Oct 20; 32(30_suppl):222. View abstract
  14. Archer NM. A diagnostic role for dense cells in sickle cell disease. Proc Natl Acad Sci U S A. 2014 Oct 14; 111(41):14647-8. View abstract
  15. Archer NM, Shmukler BE, Andolfo I, Vandorpe DH, Gnanasambandam R, Higgins JM, Rivera A, Fleming MD, Sachs F, Gottlieb PA, Iolascon A, Brugnara C, Alper SL, Nathan DG. Hereditary xerocytosis revisited. Am J Hematol. 2014 Dec; 89(12):1142-6. View abstract
  16. Hettmer S, Archer NM, Somers GR, Novokmet A, Wagers AJ, Diller L, Rodriguez-Galindo C, Teot LA, Malkin D. Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers. Cancer. 2014 Apr 01; 120(7):1068-75. View abstract
  17. Tubman VN, Archer NM. Building partnerships to target sickle cell anemia in Africa. Am J Hematol. 2013 Dec; 88(12):983. View abstract
  18. Archer NM, Le PV. Haiti: how visiting educators can help the most. Acad Med. 2013 Mar; 88(3):299-300. View abstract
  19. Archer N, Moschovis PP, Le PV, Farmer P. Perspective: postearthquake haiti renews the call for global health training in medical education. Acad Med. 2011 Jul; 86(7):889-91. View abstract